CD8A and vitiligo: So far, this is the first study that tested immune activities of all the HLA-A*0201 restricted epitopes originated from these auto-antigens in vitiligo patients, and we identified two novel critical epitopes, P28 and P119, which played dominant roles in activating CD8+T cells, thus leading to the development of vitiligo pathogenesis.